Журнал включен в российские и международные библиотечные и реферативные базы данных
РИНЦ (Россия)
Регистрационное агентство DOI (США)
Эко-Вектор (Россия)
Ulrichsweb (Ulrich’s Periodicals Director

When is calcium a friend and when is it a foe?

DOI: https://doi.org/10.29296/25879979-2023-03-10

V.I. Strukov(1), M.Yu. Sergeeva-Kondrachenko(1), O.P. Vinogradova(1), D.V. Vikhrev(1), A.G. Denisova(1), E.S. Panina(2), I.Y. Moiseeva(2), E.V. Petrova(2), V.A. Poluboyarinov(2), A.V. Fedorov(3), G.S. Brudyan(4)
1-Penza Institute for Advanced Medical Education - a branch of the Federal State Budgetary Educational Institution of Additional Professional Education «Russian Medical Academy of Continuing Professional Education» of the Ministry of Healthcare of the Russian Federation, 440060, Penza, 8A, Stasova str.
2-FGBOU VO «Penza State University» (Federal State Budgetary Educational Institution of Higher Education), 40 Krasnaya St., Penza, 440026.
3-Federal State Budgetary Educational Institution of Higher Education «Penza State Agrarian University», 30 Botanicheskaya St., Penza, 440014
4-State Autonomous Health Institution of the Moscow Region, «Voskresensk Dental Polyclinic» 140209, Moscow Region, Voskresensk, ul. Zapadnaya, 14

In the article is described the role of calcium in the human body. Possible consequences of uncontrolled intake of mineral supplements are considered. Possible reasons for their low efficiency in the therapy of bone pathologies are analyzed. The results of a large-scale study are given to answer the question: do calcium-containing drugs reduce the probability of osteoporosis and the risk of fracture? The innovative personalized approach in the therapy of musculoskeletal system diseases, which implies the use of osteoprotectors “Osteomed”, “Osteomed Forte” and “Osteo-Vit D3”, is described.

deposition of calcium salts
personalized approach
Osteomed Forte
Osteo-Vit D3.

  1. Gromova O. A., Kudrin A. V. Neurochemistry of macro- and microelements. New approaches to pharmacotherapy. M.: Alev-V, 2001. 272 с.
  2. Studenikin V. M., Kurbaitaeva E.M. Calciopenic conditions and their correction. Treating Physician. 2010; 10: 54–56.
  3. Parekh A. B., Putney J. W. Store-Operated Calcium Channels. Physiol Rew. 2005; 85: 757–810.
  4. Strukov V. I. Hypervitaminosis D and hypercalcemic states. When is calcium dangerous? monograph. Penza: State Budgetary Educational Institution of Higher Professional Education of the Ministry of Health of Russia, 2014. 194 с.
  5. Li K., Kaaks R., Linseisen J. et.al. Associations of dietary calcium intake and calcium supplementation with myocardial infarction and stroke risk and overall cardiovascular mortality in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition study (EPIC-Heidelberg). Heart. 2012; 98: 920–925.
  6. Bolland M. J., Avenell A., Baron J. A. et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: a meta-analysis. BMJ. 2010; 341: c3691.
  7. Patel A. M., Goldfarb S. Got calcium? Welcome to the calcium-alkali syndrome. J. Am. Soc. Nephrol. 2010; 21(9): 1440–1443.
  8. Gao X., LaValley M. P., Tucker K. L. Prospective studies of dairy products and calcium intakes and prostate cancer risk: a meta-analysis. J. Natl. Cancer. Inst. 2005; 97(23): 1768–1777.
  9. Tai V., Leung W., Grey A. et al. Calcium intake and bone mineral density: systematic review and meta-analysis. BMJ. 2015; 351: h4183.
  10. Bolland M. J., Leung W., Tai V. et al. Calcium intake and risk of fracture: a systematic review. BMJ. 2015; 351: h4580.
  11. Strukov V. I., Kislov A. I., Eremina N. V. et.al. The use of bone tissue non-steroid anabolizators in treatment of osteoporosis. Research Journal of Pharmacy and Technology. 2019; 12(5): 2195–2199.
  12. Strukov V.I., Elistratov D.G., Vikhrev D.V., et al. Personalized approach to diagnosis and therapy of comorbid osteoporosis in clinical practice. Vrach. 2022; 33(6): 20–25.